A Targeted, Tandem‐Activated Artificial Urinary Biomarker Sensor for Early Detection and Therapeutic Intervention of Thoracic Aortic Aneurysm and Dissection
Advanced Materials · 2026
DOI: 10.1002/adma.74390 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Jie Zhan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Guangdong Provincial Key Laboratory of Precision Medical Diagnostics, Guangdong Provincial Key Laboratory of Singl…. Hauptthemen laut MEDLINE: Aortic Aneurysm, Thoracic, Aortic Dissection. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Guangdong Association for Science and Technology Young Scientific and Technological Talents Cultivation Program, Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University, National Science Fund for Distinguished Young Scholars.
Abstract (Originalsprache)
Thoracic aortic aneurysm and dissection (TAAD) is a life‐threatening cardiovascular disorder; current clinical imaging approaches primarily detect structural abnormalities at late stages and fail to enable early diagnosis or dynamic therapeutic monitoring. Here, we develop a targeted, tandem‐activated artificial urinary biomarker sensor (TADEI) for real‐time optical imaging and urinalysis of early biomarkers associated with TAAD. After identifying biomarkers from patient tissue samples, TADEI was designed with three key components conjugated to a near‐infrared fluorophore: a VCAM‐1–targeting moiety (overexpressed on inflamed endothelial cells), tandem‐responsive substrates for caspase‐1 (an inflammation mediator) and legumain (a protease relevant to vascular remodeling), and a renal‐clearance–enabling moiety. TADEI specifically targets TAAD lesions and activates its fluorescence upon reaction with these early biomarkers after systemic administration. Meanwhile, TADEI is excreted into urine via renal clearance (≈76%), converting TAAD biomarker levels into urinary signals for optical urinalysis. In a mouse model, a TADEI‐based urine test detected TAAD at least 12 days earlier than ultrasound imaging and 16 days earlier than plasma D‐dimer assays. The correlation between the urinary signal of activated TADEI and disease severity guided intervention that effectively inhibited TAAD progression, achieving 100% survival compared with 73% for ultrasound‐guided therapy and 40% without treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Guangdong Provincial Key Laboratory of Precision Medical Diagnostics, Guangdong Provincial Key Laboratory of Single-cell and Extracellular Vesicles, Nanfang Hospital, Southern Medical…
- State Key Laboratory of Multi-organ Injury Prevention and Treatment, Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors, Guangdong Provincial Clinical Research Center For Laboratory Med…
- Guangdong Provincial Biomedical Engineering Technology Research Center For Cardiovascular Disease, Department of Cardiology and Laboratory of Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou, Chin…
- National Engineering Research Centre for Nanomedicine, College of Life Science and Technology, Hubei Key Laboratory of Bioinorganic Chemistry and Materia Medical, Huazhong University of Science and Technology, Wuhan, Ch…
- State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
- School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore, Singapore.
ORCID-Profile: Jie Zhan, Penghui Cheng, Yan Zhang, Yanbin Cai, Lei Zheng, Kanyi Pu
Förderung
- Guangdong Association for Science and Technology Young Scientific and Technological Talents Cultivation Program
- Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University
- National Science Fund for Distinguished Young Scholars
- Singapore National Research Foundation
- National Natural Science Foundation of China
- National Research Foundation Singapore
Zitieren
APA
Zhan, J., Lin, Z., Yu, J., Cheng, P., Luo, S., Chen, J., Hu, Y., Wang, X., Zhang, Y., Cai, Y., Zheng, L., & Pu, K. (2026). A Targeted, Tandem‐Activated Artificial Urinary Biomarker Sensor for Early Detection and Therapeutic Intervention of Thoracic Aortic Aneurysm and Dissection. Advanced Materials. https://doi.org/10.1002/adma.74390
Vancouver
Zhan J, Lin Z, Yu J, Cheng P, Luo S, Chen J, et al. A Targeted, Tandem‐Activated Artificial Urinary Biomarker Sensor for Early Detection and Therapeutic Intervention of Thoracic Aortic Aneurysm and Dissection. Advanced Materials. 2026. doi:10.1002/adma.74390
BibTeX
@article{Zhan2026,
author = {Zhan, Jie and Lin, Zien and Yu, Jie and Cheng, Penghui and Luo, Siman and Chen, Jieling and Hu, Yuxuan and Wang, Xiaowu and Zhang, Yan and Cai, Yanbin and Zheng, Lei and Pu, Kanyi},
title = {A Targeted, Tandem‐Activated Artificial Urinary Biomarker Sensor for Early Detection and Therapeutic Intervention of Thoracic Aortic Aneurysm and Dissection},
journal = {Advanced Materials},
year = {2026},
doi = {10.1002/adma.74390}
}
EUVIMED